These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26958802)

  • 61. Cross-Systems Care Integration Impact on Adults With Intellectual Disability Utilizing Risk Weight and Comorbidity Data: A Comparative Effectiveness Study, 2014-2017.
    Wilson T; Geer B; Guerra N; Karber B; Ervin DA
    Intellect Dev Disabil; 2020 Oct; 58(5):422-431. PubMed ID: 33032319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Health disparities and intellectual disabilities: lessons from individuals with Down syndrome.
    Ploeg Booth KV
    Dev Disabil Res Rev; 2011; 17(1):32-5. PubMed ID: 22447753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A system-level study of initiation, engagement, and equity in outpatient substance use treatment.
    Urbanoski K; Kenaszchuk C; Inglis D; Rotondi NK; Rush B
    J Subst Abuse Treat; 2018 Jul; 90():19-28. PubMed ID: 29866380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictors of Emergency Room and Hospital Utilization Among Adults With Intellectual and Developmental Disabilities (IDD).
    Blaskowitz MG; Hernandez B; Scott PW
    Intellect Dev Disabil; 2019 Apr; 57(2):127-145. PubMed ID: 30920909
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance-based contracting within a state substance abuse treatment system: a preliminary exploration of differences in client access and client outcomes.
    Brucker DL; Stewart M
    J Behav Health Serv Res; 2011 Jul; 38(3):383-97. PubMed ID: 21249461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management and prevalence of long-term conditions in primary health care for adults with intellectual disabilities compared with the general population: A population-based cohort study.
    Cooper SA; Hughes-McCormack L; Greenlaw N; McConnachie A; Allan L; Baltzer M; McArthur L; Henderson A; Melville C; McSkimming P; Morrison J
    J Appl Res Intellect Disabil; 2018 Jan; 31 Suppl 1():68-81. PubMed ID: 28730746
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Substance use and abuse in individuals with mild intellectual disability or borderline intellectual functioning: An introduction to the special section.
    Didden R
    Res Dev Disabil; 2017 Apr; 63():95-98. PubMed ID: 28222960
    [No Abstract]   [Full Text] [Related]  

  • 68. Self- and proxy-rated needs in adults with mild to moderate intellectual disabilities: Perspective matters.
    Schützwohl M; Voß E; Salize HJ; Stiawa M; Puschner B; Koch A
    J Appl Res Intellect Disabil; 2018 Mar; 31(2):285-295. PubMed ID: 28834006
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Moving beyond access: towards a quality-orientated substance abuse treatment system in South Africa.
    Myers B; Petersen Z; Kader R; Parry CD
    S Afr Med J; 2012 Jun; 102(8):667-8. PubMed ID: 22831942
    [No Abstract]   [Full Text] [Related]  

  • 70. Medicaid coverage and access to publicly funded opiate treatment.
    Deck DD; Wiitala WL; Laws KE
    J Behav Health Serv Res; 2006 Jul; 33(3):324-34. PubMed ID: 16752109
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Health behaviours and mental health status of parents with intellectual disabilities: cross sectional study.
    Emerson E; Brigham P
    Public Health; 2013 Dec; 127(12):1111-6. PubMed ID: 24275031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disabilities, developmental handicaps, and substance misuse: a review.
    Moore D; Polsgrove L
    Int J Addict; 1991 Jan; 26(1):65-90. PubMed ID: 1829719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gender and use of substance abuse treatment services.
    Green CA
    Alcohol Res Health; 2006; 29(1):55-62. PubMed ID: 16767855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Indicators of substance abuse treatment demand in Cape Town, South Africa (1997-2001).
    Myers B; Parry CD; Plüddemann MA
    Curationis; 2004 May; 27(2):27-31. PubMed ID: 15974017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The POMONA-ESP project methodology: Collecting data on health indicators for people with intellectual developmental disorders.
    Folch A; Martínez-Leal R; Vicens P; Irazábal M; Muñoz S; Salvador-Carulla L; Rovira L; Orejuela C; Cortés MJ
    J Appl Res Intellect Disabil; 2019 Jan; 32(1):15-22. PubMed ID: 30009410
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lifestyle related risk factors for poor health in residential settings for people with intellectual disabilities.
    Robertson J; Emerson E; Gregory N; Hatto C; Turner S; Kessissoglou S; Hallam A
    Res Dev Disabil; 2000; 21(6):469-86. PubMed ID: 11153830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gender differences in barriers to alcohol and other drug treatment in Cape Town, South Africa.
    Myers B; Louw J; Pasche S
    Afr J Psychiatry (Johannesbg); 2011 May; 14(2):146-53. PubMed ID: 21687914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Health needs of women with mental retardation and developmental disabilities.
    Lunsky Y; Reiss S
    Am Psychol; 1998 Mar; 53(3):319. PubMed ID: 9515308
    [No Abstract]   [Full Text] [Related]  

  • 79. Age at Death in Individuals with Intellectual Disabilities.
    Arvio M; Salokivi T; Bjelogrlic-Laakso N
    J Appl Res Intellect Disabil; 2017 Jul; 30(4):782-785. PubMed ID: 27364954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Disparities in access to a dermatologist for acne care in the United States.
    Patel VM; Schwartz RA
    Int J Dermatol; 2017 Jun; 56(6):e131-e133. PubMed ID: 28247921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.